|

ICS/LABA Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since May 2026

Also known as: fluticasone, inhalation aerosol, propionate/salmeterol HFA

Pipeline

Phase 2: 1

Top Sponsors

  • Incyte Corporation1

Indications

  • Moderate to Severe Asthma1
  • Asthma1

Birmingham, Alabama1 trial

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

Allervie Clinical Research

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.